ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
Emergent Pledges FDA Improvements at Troubled Vaccine Plant
June 15, 2021Emergent BioSolutions is promising the FDA a series of fixes in response to an inspection that led to production stopping at the company's Bayview facility in Baltimore, which had been making Johnson & Johnson's COVID-19 vaccine, reported Bloomberg. -
Further woes for Emergent’s Bayview vaccine production facility
April 26, 2021An FDA inspection identified nine concerns including unsanitary conditions and ineffective practices for preventing cross-contamination at Emergent’s facility. -
FDA halts COVID-19 vaccine production at Emergent facility
April 22, 2021The FDA has requested Emergent’s Bayview plant be closed and vaccine production halted while the agency investigates potential good manufacturing practice (GMP) violations. -
Millions of J&J Covid-19 vaccine doses scrapped after US ingredient mix-up
April 02, 2021Up to 15 million doses of Johnson & Johnson’s (J&J) Covid-19 vaccine have been ruined due to a mix-up with ingredients at a US production plant.
Pharma Sources Insight January 2025
